— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
P/E
3.07×
only 7 monthly observations — under the 12-month floor for a series line. P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
−60.1% (2017-01)
—
no band (12 mo · 1 distinct)
—
—
−36.9%
12 · 1
ROIC
—
no reconstructed observations for this name and metric.
39.2%
−270.5%
97th
+0.89σ
−21.3%
139 · 12
12.6%
−5.3%
70th
−0.18σ
5.1%
141 · 140
EPS Growth 3Y
—
P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
−17.2%
6.7%
3rd
−0.79σ
9.0%
102 · 9
Market Cap
$1.31B
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
ROE (point-in-time)Health Care median, same monthshaded = own p25–p75
Multiple-implied price ladder · Full
Filed earnings only.
no P/E ladder — only 7 monthly observations — under the 12-month floor for a series line. P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
Ladder not drawn for this name — the reason is above.ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
Covered pool$977.78B +7.6%/yr 2020→2025Concentration484 of 10,000fragmented · top 3 hold 22.9% · −24 pts since 2020NVAX0.1% · rank 47 of 348 · +0.0pp over 5y· CV 0.94 · σ 0.1pp
Who holds the poolCY2025 · bars scaled to the largest member
Growth, restated as sharewhere each pace has to END UP, by 2030
Its own realised pace0.1% → 0.0%
The pace the price requires— The growth today's price requires (our reverse-DCF) is a Pro metric — the realized-pace runway above is free.
NVAX share over timelast 6 of 10 published years
Calendar year
2020
2021
2022
2023
2024
2025
Share of covered pool
0.1%
0.1%
0.2%
0.1%
0.1%
0.1%
coverage: 321 of the 385 members that…
Share of covered industry revenue · n=348 in Pharmaceuticals & Biotechnology · CY2025 pool · built 2026-08-20 not market shareⓘ
Covered filers only, not market share — private and uncovered companies are missing, so every share here reads high. Years are FX-converted and published only once most of the pool has filed.
